Cargando…

Lead Discovery Using Virtual Screening

The practice of virtual screening (VS) to identify chemical leads to known or novel targets is becoming a core function of the computational chemist within industry. By employing a range of techniques, when attempting to identify compounds with activity against a biological target, a small focused s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bikker, Jack Andrew, Narasimhan, Lakshmi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176223/
http://dx.doi.org/10.1007/7355_2009_3
_version_ 1783524980504395776
author Bikker, Jack Andrew
Narasimhan, Lakshmi S.
author_facet Bikker, Jack Andrew
Narasimhan, Lakshmi S.
author_sort Bikker, Jack Andrew
collection PubMed
description The practice of virtual screening (VS) to identify chemical leads to known or novel targets is becoming a core function of the computational chemist within industry. By employing a range of techniques, when attempting to identify compounds with activity against a biological target, a small focused subset of a larger collection of compounds can be identified and tested, often with results much better than selecting a similar number of compounds at random. We will review the key methods available, their relative success, and provide practical insights into best practices and key gaps. We will also argue that the capability of VS methods has grown to a point where fuller integration with experimental methods, including HTS, could increase the effectiveness of both.
format Online
Article
Text
id pubmed-7176223
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-71762232020-04-22 Lead Discovery Using Virtual Screening Bikker, Jack Andrew Narasimhan, Lakshmi S. Lead-Seeking Approaches Article The practice of virtual screening (VS) to identify chemical leads to known or novel targets is becoming a core function of the computational chemist within industry. By employing a range of techniques, when attempting to identify compounds with activity against a biological target, a small focused subset of a larger collection of compounds can be identified and tested, often with results much better than selecting a similar number of compounds at random. We will review the key methods available, their relative success, and provide practical insights into best practices and key gaps. We will also argue that the capability of VS methods has grown to a point where fuller integration with experimental methods, including HTS, could increase the effectiveness of both. 2009-08-06 /pmc/articles/PMC7176223/ http://dx.doi.org/10.1007/7355_2009_3 Text en © Springer-Verlag Berlin Heidelberg 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Bikker, Jack Andrew
Narasimhan, Lakshmi S.
Lead Discovery Using Virtual Screening
title Lead Discovery Using Virtual Screening
title_full Lead Discovery Using Virtual Screening
title_fullStr Lead Discovery Using Virtual Screening
title_full_unstemmed Lead Discovery Using Virtual Screening
title_short Lead Discovery Using Virtual Screening
title_sort lead discovery using virtual screening
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176223/
http://dx.doi.org/10.1007/7355_2009_3
work_keys_str_mv AT bikkerjackandrew leaddiscoveryusingvirtualscreening
AT narasimhanlakshmis leaddiscoveryusingvirtualscreening